Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Blood|November 8, 2019
The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negativeSanjay S Patel, Jason L Weirather, Mikel Lipschitz, et al.
Blood|May 12, 2017
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphomaPier Luigi Zinzani, Vincent Ribrag, Craig H Moskowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007
A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Corey S Cutler, et al.
Transplantation and Cellular Therapy|March 5, 2025
Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab TherapyJohn Kuruvilla, Philippe Armand, Alex F Herrera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2010
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced ageJohn Koreth, Julie Aldridge, Haesook T Kim, et al.
American Journal of Surgery|March 14, 2019
Emergency general surgery procedures in hematopoietic stem cell transplant recipientsSharven Taghavi, Manuel Castillo-Angeles, Tarsicio Uribe-Leitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host DiseaseNathaniel Treister, Shuli Li, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Leukemia|August 22, 2020
A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patientsMatthew S Davids, David C Fisher, Svitlana Tyekucheva, et al.
Leukemia & Lymphoma|May 11, 2019
Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemiaJacob D Soumerai, Matthew S Davids, Lillian Werner, et al.
Pageof 27